Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.68 USD | -3.98% | -0.44% | +51.94% |
May. 28 | Nurix Therapeutics, Inc. Appoints Paula G. O?Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer | CI |
May. 20 | Nurix Therapeutics Names New Board Chair | MT |
Financials (USD)
Sales 2024 * | 71.27M | Sales 2025 * | 66.83M | Capitalization | 930M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -221M | EV / Sales 2024 * | 8.89 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 297M | EV / Sales 2025 * | 9.48 x |
P/E ratio 2024 * |
-5.32
x | P/E ratio 2025 * |
-4.72
x | Employees | 284 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.82% |
1 day | -3.98% | ||
1 week | -0.44% | ||
Current month | -0.44% | ||
1 month | +12.40% | ||
3 months | +5.59% | ||
6 months | +82.33% | ||
Current year | +51.94% |
Managers | Title | Age | Since |
---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 58 | 14-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Judith Reinsdorf
BRD | Director/Board Member | 60 | 21-09-30 |
Paul Silva
BRD | Director/Board Member | 58 | 21-09-30 |
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 15.68 | -3.98% | 322,090 |
24-06-06 | 16.33 | -3.14% | 426,869 |
24-06-05 | 16.86 | +5.71% | 516,565 |
24-06-04 | 15.95 | -0.62% | 520,160 |
24-06-03 | 16.05 | +1.90% | 599,519 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.94% | 930M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+2.27% | 22.78B | |
-11.02% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- NRIX Stock